A major discovery in cancer investigation is occurring with the use of VHH fragments to reactivate mutated p53. This essential malignant inhibitor protein is frequently disabled in several types of tumors, causing https://guideyoursocial.com/story7039280/nanobodies-revive-tumor-suppressor-p53-the-new-pathway-for-tumor-therapy